Pantoprazole & Domperidone Combination – PPNEXT-DSR

Pantoprazole and Domperidone is a widely used combination therapy for acid-related disorders such as gastroesophageal reflux disease (GERD), acidity, and dyspepsia. Pantoprazole reduces acid secretion in the stomach, while Domperidone improves gastric motility and prevents nausea. Together, this dual-action therapy, available as PPNEXT-DSR Capsules, provides effective and long-lasting relief.

How Does the Combination Work?

Pantoprazole is a proton pump inhibitor (PPI) that blocks acid secretion at its source. Domperidone is a prokinetic agent that enhances stomach emptying and prevents reflux-related nausea. This dual mechanism provides rapid symptom relief and better healing of gastric ulcers and reflux esophagitis.

Key Benefits of PPNEXT-DSR

• Provides quick and sustained relief from acidity and heartburn.
• Promotes faster ulcer healing in GERD and peptic ulcer disease.
• Prevents bloating, nausea, and regurgitation caused by reflux.
• Improves digestion by enhancing gastric motility.

About PPNEXT-DSR Capsules

PPNEXT-DSR Capsules contain Pantoprazole 40 mg and Domperidone 30 mg (sustained release). This formulation ensures once-daily dosing with consistent therapeutic effect throughout the day.

Who Should Use PPNEXT-DSR?

Patients suffering from GERD, chronic acidity, gastritis, peptic ulcers, and reflux-induced nausea benefit most from this therapy. It is especially effective in individuals requiring long-term acid control.

Conclusion

For comprehensive management of acidity, reflux, and indigestion, PPNEXT-DSR Capsules combine acid suppression with prokinetic support, making them a trusted choice for doctors and patients.